 |
NORD's 2012 Report to the Communities
|
 |
NORD's Newsletter: Summer 2013
|

|
NORD e-News
|
 |
NORD's Newsletter: Winter 2012
|
|
 |
NORD's Newsletter: Summer 2012
|
|

|
NORD's Newsletter: Fall 2011
|

|
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
(Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders)
|
 |
NORD's Newsletter: Fall 2010
|
 |
NORD's 2010 Annual Report
|
 |
NORD's 2009 Annual Report
|